Sanofi to acquire Bioverativ for $11.6 billion
Sanofi plans to buy biopharmaceutical company Bioverativ Inc. in a deal valued at $11.6 billion. Waltham, Mass.-based Bioverativ specializes in therapies for hemophilia and other rare blood disorders.
Sanofi plans to buy biopharmaceutical company Bioverativ Inc. in a deal valued at $11.6 billion. Waltham, Mass.-based Bioverativ specializes in therapies for hemophilia and other rare blood disorders.
Amneal Pharmaceuticals has rolled out budesonide capsules 3 mg, a medication for Crohn’s disease. Amneal said its budesonide capsules are a generic version of Entocort EC from AstraZeneca plc. The generic product has begun shipping to wholesalers, distributors and direct to the trade, Amneal added.
Middle age and older Americans see their local pharmacy as a destination for preventive care and other health services, beyond filling prescriptions and managing medications, according to the Shortcut To Health survey by PrescribeWellness. The online survey of more than 1,000 U.S.
Longtime CVS merchandising and beauty executive Cheryl Mahoney has passed away after a long illness, Chain Drug Review has learned.
Target Corp. chairman and chief executive officer Brian Cornell has been elected as chairman of the Retail Industry Leaders Association (RILA). The association said Cornell was named RILA chairman yesterday at its board of directors’ semiannual meeting in Tucson, Ariz.
Sebastian James is joining Walgreens Boots Alliance (WBA) as senior vice president and as president and managing director of Boots, the company’s international pharmacy, health and beauty chain based in the United Kingdom.
A new beauty brand aimed at tweens and teens — two burgeoning groups of makeup consumers — is set to launch this weekend. Called C’est Moi, the startup —a division of JAKKS Pacific Inc. — will offer skin care and color cosmetics specifically for 8- to 16-year-old girls. The company said
Intermountain Healthcare, Ascension, SSM Health and Trinity Health, in consultation with the U.S. Department of Veterans Affairs — said the new company will make key generic medications more available and
Seeking lower prices and added convenience, more U.S. shoppers are going online to buy consumer packaged goods (CPG), according to market researcher IRI.
Retail veteran Kathi Lentzsch has joined regional pharmacy chain Bartell Drugs as chief executive officer. Lentzsch, most recently interim CEO of Gump’s, a luxury specialty store and direct-to-consumer retailer based in San Francisco, marks only the fifth chief executive in Bartell Drugs’ history.
Australia-based a2 Milk Company, which describes itself as a “dairy nutrition company,” is expanding its retail distribution into the northeastern United States.
The National Association of Chain Drug Stores and the National Community Pharmacists Association have submitted comments to the Centers for Medicare & Medicaid Services (CMS) as it mulls Medicare Part D prescription drug program changes for the 2019 contract year.
After being granted a priority review from the Food and Drug Administration this past fall, Boehringer Ingelheim Pharmaceuticals Inc. has received approval of its supplemental New Drug Application (sNDA) for Gilotrif (afatinib), a lung cancer medication.
Nuvo Pharmaceuticals Inc. has acquired the U.S. rights to over-the-counter lice treatment Resultz from Piedmont Pharmaceuticals LLC. Nuvo said the purchase of U.S.
The Nature’s Bounty Co. has named Bob Goode chief customer officer in the U.S.
Walmart has promoted Judith McKenna, executive vice president and chief operating officer for Walmart U.S., to president and chief executive officer of Walmart International. The retail giant said Wednesday that McKenna will assume the new role on Feb.